“Digoxin toxicity”的搜索结果，显示 441-450 项，共有 11917 项
... toxicity. Patient demographics, adverse events, and comorbidities will also ... Key secondary endpoints are toxicity, end-Induction response, and overall survival ...
Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...
... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...
The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...
... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...
... toxicities (DLT) and the maximum ... Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs.
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。